Serotonin Pathway Tied to SSRI-Linked Tinnitus, Hinting at Targeted Therapies
New mouse research identifies a specific serotonin-driven circuit from the dorsal raphe nucleus to the auditory system that, when elevated, induces tinnitus-like behavior; turning off this circuit reduces symptoms, providing a potential path to precision drugs that keep antidepressant benefits without worsening tinnitus. The findings help explain why some people on SSRIs experience tinnitus and emphasize the need for clinicians to balance mood relief with ear-related side effects rather than stopping medication abruptly.
